1. Home
  2. SKYW vs CPRX Comparison

SKYW vs CPRX Comparison

Compare SKYW & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$94.77

Market Cap

3.6B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$25.91

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
CPRX
Founded
1972
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
2.9B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
SKYW
CPRX
Price
$94.77
$25.91
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$123.67
$35.00
AVG Volume (30 Days)
315.5K
1.0M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
28.24
EPS
10.35
1.68
Revenue
$2,971,963,000.00
$119,072,803.00
Revenue This Year
$8.35
$9.20
Revenue Next Year
$3.55
$10.51
P/E Ratio
$9.37
$15.38
Revenue Growth
N/A
16.39
52 Week Low
$82.14
$19.05
52 Week High
$123.94
$26.56

Technical Indicators

Market Signals
Indicator
SKYW
CPRX
Relative Strength Index (RSI) 52.19 60.90
Support Level $94.62 $22.24
Resistance Level $95.75 N/A
Average True Range (ATR) 3.21 0.66
MACD 0.81 0.16
Stochastic Oscillator 55.70 81.28

Price Performance

Historical Comparison
SKYW
CPRX

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: